Author: Bill Snyder
The exocyst dynamo
Dec. 13, 2018—New methods have revealed details of vesicle trafficking in cells and are applicable to any protein complexes, potentially revolutionizing our understanding of cell dynamics.
Team spots clue to rare lung and kidney diseases
Dec. 6, 2018—Pulmonary-renal syndrome (PRS) refers to a group of rare but potentially fatal conditions that nearly always are caused by a misguided attack by the body’s immune system on the lungs and kidneys. Coughing up blood and blood in the urine are telltale signs.
Discovery could lead to neutralizing West Nile virus
Dec. 6, 2018—Researchers at Vanderbilt University Medical Center and colleagues have isolated a human monoclonal antibody that can “neutralize” the West Nile virus and potentially prevent a leading cause of viral encephalitis (brain inflammation) in the United States.
Five faculty elected AAAS fellows
Nov. 29, 2018—Five Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.
McLaughlin, Casagrande honored by the Society for Neuroscience
Nov. 29, 2018—Two Vanderbilt University scientists — BethAnn McLaughlin, PhD, and the late Vivien Casagrande, PhD — have been honored by the Society for Neuroscience for making significant contributions to the advancement of women in science.
Beta cell biomarker findings may speed diabetes research
Nov. 29, 2018—Researchers at Vanderbilt University Medical Center have identified a biomarker for insulin-producing beta cells. Their finding, reported this month in the journal Cell Metabolism, could lead to improved ways to study and treat diabetes.
Vanderbilt study suggests way to prevent rare lung disease
Nov. 15, 2018—Research by Vanderbilt scientists suggests that it may be possible to prevent or even reverse pulmonary arterial hypertension, a rare, progressive disease characterized by narrowing of and high blood pressure in the small arteries of the lungs.
Lynn Maquat, PhD, to give Vanderbilt Prize lecture Nov. 29
Nov. 15, 2018—Lynne Maquat, PhD, recipient of the 2017 Vanderbilt Prize in Biomedical Science whose work has advanced our understanding of human gene expression, will deliver her Vanderbilt Prize lecture as part of the Flexner Discovery Lecture series on Nov. 29.
Harrison awarded AHA Basic Research Prize for 2018
Nov. 15, 2018—David G. Harrison, MD, the Betty and Jack Bailey Professor of Cardiology and director of the Division of Clinical Pharmacology at Vanderbilt University School of Medicine, has been awarded the American Heart Association’s Basic Research Prize for 2018.
Four researchers receive Young Investigator Grants
Nov. 15, 2018—Four Vanderbilt University researchers are among 200 recipients of this year’s Young Investigator Grants awarded by the Brain & Behavior Research Foundation to support “innovative ideas for groundbreaking neurobiological research.”
Center for Addiction Research Science Day slated for Nov. 16
Nov. 8, 2018—Margaret Haney, PhD, director of the Cannabis Research Laboratory at Columbia University Medical Center, will discuss “The Yin and Yang of Cannabis,” Friday, Nov. 16, during the second annual Science Day hosted by the Vanderbilt Center for Addiction Research (VCAR).
Cardiovascular disease expert Ridker set for Oates Lectureship
Nov. 8, 2018—Paul Ridker, MD, MPH, the Eugene Braunwald Professor of Medicine at Harvard Medical School, will present the 12th annual Meredith S. and John A. Oates Lectureship in Clinical Pharmacology, on Thursday, Nov. 15, during Medicine Grand Rounds.
